For example, Atracurium Besylate (an nAChR antagonist) (Spina et al. (2016) [93]) and StN2/4/8 (α7 and α9/α10 nAChR antagonists) (Pucci et al. (2022) [91]; Bavo et al. (2023) [94]) have been shown to have significant inhibitory effects on GBM cell line vitality. Here, CHRNA4 is linked to glioblastoma.